LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) concerning the Company and its officers’ possible violations of federal securities laws. GPM is preparing a lawsuit on behalf of injured investors.
On June 2, 2016, Citron Research released a report asserting that Chemours, a spin-off from DuPont, “is the most morally and financially bankrupt company that we have ever witnessed.” The Citron report further alleges that Chemours is just the “latest chapter in a well documented 60+ year pattern of wanton and deliberate abuse of humanity, the environment and now the capital markets.” The Citron report also alleges that Chemours is responsible for dumping a toxic chemical known as C8, aka PFOA, into the drinking water of millions of people; and, therefore can face very large future liabilities.
On this news, shares of Chemours have fallen nearly 10% to just $7.99 per share during intra-day trading on June 2, 2016.
If you purchased Chemours securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to firstname.lastname@example.org, or visit our website at http://www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.